Risperidone and the Treatment of Psychiatric, Motor, and Cognitive Symptoms in Huntington's Disease

被引:53
作者
Duff, Kevin [1 ]
Beglinger, Leigh J. [1 ]
O'Rourke, Margaret E. [1 ]
Nopoulos, Peg [1 ]
Paulson, Henry L. [2 ,3 ]
Paulsen, Jane S. [1 ,2 ]
机构
[1] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA
[3] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
关键词
Huntington's disease; Risperidone; Treatment; Psychiatric symptoms; Motor; Cognition;
D O I
10.1080/10401230701844802
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background. Huntington's disease (HD) is a progressive, neuropsychiatric disorder, and limited reports indicate that risperidone might improve motor and psychiatric functioning for these patients. Methods. In a retrospective, chart review study to evaluate the effectiveness of risperidone on motor, psychiatric, and cognitive functioning in HD, 17 patients taking risperidone in the course of clinical care and 12 patients not taking any antipsychotic medication were compared across a year, Results. Patients taking risperidone demonstrated significantly improved psychiatric,functioning and motor stabilization, whereas patients not taking risperidone were stable psychiatrically and worsened motorically. Conclusions. Although controlled clinical trials are clearly needed, these preliminary, results support the use of risperidone in patients with HD in treating their psychiatric and possibly motor symptoms.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 14 条
[1]  
[Anonymous], 1989, QUANTIFICATION NEURO
[2]   Probability of obsessive and compulsive symptoms in Huntington's disease [J].
Beglinger, Leigh J. ;
Langbehn, Douglas R. ;
Duff, Kevin ;
Stierman, Laura ;
Black, Donald W. ;
Nehl, Carissa ;
Anderson, Karen ;
Penziner, Elizabeth ;
Paulsen, Jane S. .
BIOLOGICAL PSYCHIATRY, 2007, 61 (03) :415-418
[3]   A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia [J].
Brodaty, H ;
Ames, D ;
Snowdon, J ;
Woodward, M ;
Kirwan, J ;
Clarnette, R ;
Lee, E ;
Lyons, B ;
Grossman, F .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) :134-143
[4]   Effectiveness of risperidone in Huntington chorea patients [J].
Dallocchio, C ;
Buffa, C ;
Tinelli, C ;
Mazzarello, P .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) :101-103
[5]   Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone [J].
De Deyn, PP ;
Katz, IR ;
Brodaty, H ;
Lyons, B ;
Greenspan, A ;
Burns, A .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (06) :497-508
[6]   Risperidone in chorea and psychosis of Huntington's disease [J].
Erdemoglu, AK ;
Boratav, C .
EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (02) :182-183
[7]  
Madhusoodanan S, 1998, AM J GERIAT PSYCHIAT, V6, P347
[8]   Rate of functional decline in Huntington's disease [J].
Marder, K ;
Zhao, H ;
Myers, RH ;
Cudkowicz, M ;
Kayson, E ;
Kieburtz, K ;
Orme, C ;
Paulsen, J ;
Penney, JB ;
Siemers, E ;
Shoulson, I .
NEUROLOGY, 2000, 54 (02) :452-458
[9]   Tetrabenazine as antichorea therapy in Huntington disease - A randomized controlled trial [J].
Marshall, FJ ;
Walker, F ;
Frank, S ;
Oakes, D ;
Plumb, S ;
Factor, SA ;
Fahn, S ;
Hunt, VP ;
Jankovic, J ;
Shinaman, A ;
Shoulson, I ;
Goldstein, J ;
Corey-Bloom, J ;
Belden, J ;
Wojcieszek, J ;
Nickerson, C ;
Higgins, D ;
McCall, M ;
Sanchez-Ramos, J ;
Stepanov, N ;
Kostyk, S ;
Harrison, J ;
Testa, C ;
Shannon, B ;
Feigin, A ;
Radtke, D ;
Nance, M ;
Stanton, P ;
Ashizawa, T ;
Hunter, C ;
Ondo, W ;
Rose, K ;
Geschwind, M ;
Jaglin, J ;
Shannon, K ;
Matthews, M ;
Colcher, A ;
Riendl, P ;
Blindauer, K ;
Dustin, K ;
Anderson, K ;
Fowler, S ;
Mehta, D ;
Hanna, P ;
Lindsay, P ;
Eberly, S ;
Zhao, HW ;
MacDonald, M ;
Young, A .
NEUROLOGY, 2006, 66 (03) :366-372
[10]  
Marshall FJ, 2003, NEUROLOGY, V61, P1551